scholarly article | Q13442814 |
P356 | DOI | 10.3109/02841851003782059 |
P698 | PubMed publication ID | 20429756 |
P50 | author | Jana Rydland | Q114422036 |
Tone F. Bathen | Q61104171 | ||
Kjell Arne Kvistad | Q64213708 | ||
Ingrid Susann Gribbestad | Q65706743 | ||
Steinar Lundgren | Q65706815 | ||
Pål Erik Goa | Q92895190 | ||
Mariann G Heldahl | Q114422031 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 604-612 | |
P577 | publication date | 2010-07-01 | |
P1433 | published in | Acta Radiologica | Q4033350 |
P1476 | title | Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis | |
P478 | volume | 51 |
Q37721539 | Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer |
Q39547119 | Association between survival in patients with primary invasive breast cancer and computer aided MRI. |
Q39262277 | Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis |
Q44491240 | Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy |
Q48265826 | Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results. |
Q61809423 | Contrast-enhanced ultrasound for evaluating the pathologic response of breast cancer to neoadjuvant chemotherapy: A meta-analysis |
Q30460977 | Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. |
Q37093041 | DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings |
Q37292720 | Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer |
Q35926256 | Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes |
Q38752236 | Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. |
Q34016780 | In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response |
Q36853113 | MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers |
Q53213556 | Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T? |
Q35866905 | Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy |
Q86054997 | Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators |
Search more.